scholarly journals Restenosis after carotid angioplasty and stenting: A follow-up study with duplex ultrasonography

2003 ◽  
Vol 26 (2) ◽  
pp. 141-144 ◽  
Author(s):  
M.H. Christiaans ◽  
J.M.P.G. Ernst ◽  
M.J. Suttorp ◽  
J.C. van den Berg ◽  
T.Th.C. Overtoom ◽  
...  
Keyword(s):  
Duplex Ultrasonography ◽  
Carotid Angioplasty ◽  
Follow Up Study ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Retinal Embolization During Carotid Angioplasty and Stenting: Periprocedural Data and Follow-Up

2009 ◽  
Vol 33 (4) ◽  
pp. 714-719 ◽  
Author(s):  
J. A. Vos ◽  
M. H. van Werkum ◽  
J. H. G. M. Bistervels ◽  
R. G. A. Ackerstaff ◽  
S. C. Tromp ◽  
...  
Keyword(s):  
Carotid Angioplasty ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

scholarly journals Safety and Efficacy of Flow Reversal in Acute and Elective Carotid Angioplasty and Stenting Using the Mo.Ma Device with Short-Term Follow-Up

2019 ◽  
Vol 8 (2-6) ◽  
pp. 196-205
Author(s):  
Ambooj Tiwari ◽  
Ryan Bo ◽  
Keithan Sivakumar ◽  
Karthikeyan M. Arcot ◽  
Philip Ye ◽  
...  
Keyword(s):  
Flow Reversal ◽  
Carotid Angioplasty ◽  
Short Term ◽  
Safety And Efficacy ◽  
Carotid Revascularization ◽  
Subacute Stroke ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting ◽  
Radiographic Data

Objective: To determine the safety and efficacy of flow reversal following proximal flow arrest as an embolic protection strategy for carotid angioplasty and stenting (CAS) with short-term follow-up. Method: We performed a retrospective review of our CAS database for patients who underwent stent-supported carotid revascularization in the setting of acute/subacute stroke or TIA. We reviewed clinical and radiographic data during a 36-month period. Primary outcome was clinical evidence of ipsilateral stroke in the first 30 days. Secondary outcomes include clinical outcomes and sonographic and/or angiographic follow-up over 6 months, 6-month functional scale, and all-cause mortality. Results: Fifty-five patients underwent CAS using flow reversal: 26 females and 29 males with a mean age of 69.7 years. Median time to treatment from index event was 3 days. 11% underwent stenting as part of hyperacute stroke therapy. Average luminal stenosis was 86%. The 9-Fr Mo.Ma device was used in combination with Penumbra aspiration in all cases. There were no ipsilateral strokes. Incidence of any ischemic event was 3.64%, but only 1 (1.82%) patient had a postoperative stroke. Clinical follow-up was available for 94.5%, while lesion follow-up was available for 73% of patients. Three patients had evidence of restenosis, but none were symptomatic. Luminal restenosis was ≤30% in all three. Median pre- and post-NIHSS were 1 and 1, respectively. Conclusion: Flow reversal using the Mo.Ma device is a safe and effective strategy in preventing distal embolization during carotid artery revascularization.

Carotid Angioplasty and Stenting is a Safe and Durable Procedure in a Community Hospital

2007 ◽  
Vol 73 (6) ◽  
pp. 543-546
Author(s):  
Mark L. Friedell ◽  
Bryan J. Sandler ◽  
Joseph G. Andriole ◽  
Samuel P. Martin ◽  
Michael J. Cohen ◽  
...  
Keyword(s):  
High Risk ◽  
Community Hospital ◽  
Hospital Setting ◽  
Long Term Results ◽  
Carotid Angioplasty ◽  
Stroke Mortality ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Carotid angioplasty and stenting (CAS) has been touted as a reasonable alternative to carotid endarterectomy (CEA) for high-risk surgical candidates. Several published CAS series, primarily from academic centers, show immediate results approaching those of CEA. However, very little is known about long-term results with CAS, particularly in the community hospital setting. Therefore, we retrospectively reviewed our CAS experience. From February 1999 to July 2003, 44 consecutive patients underwent placement of 46 stents. The mean patient age was 73 years, and 57 per cent were men. Most patients were asymptomatic (74%). High-risk categories included prior CEA (71%), other anatomic risks (13%), and/or significant medical comorbidities (16%). Technical success was achieved in all 46 cases. At 30 days, there were no deaths and one stroke, giving a combined stroke/mortality of 2 per cent. Clinical follow-up was obtained on all 44 patients at a mean follow-up of 42 months. Duplex scans performed on 44 stents (96%), at a mean follow-up of 40 months, demonstrated four 60 per cent to 79 per cent recurrent stenoses. CAS in a community hospital can have a 30-day stroke/mortality equivalent to CEA. The procedure is durable, with no critical (80%–99%) carotid restenoses and no stroke or transient ischemic attacks referable to a stented carotid artery in long-term follow-up.

scholarly journals 1156-64 Carotid angioplasty and stenting: Early and late follow-up results

2004 ◽  
Vol 43 (5) ◽  
pp. A91
Author(s):  
Raffaella Manetti ◽  
Castriota Fausto ◽  
Enrico Ricci ◽  
Armando Liso ◽  
Kareem Oshoala ◽  
...  
Keyword(s):  
Carotid Angioplasty ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

scholarly journals Carotid angioplasty and stenting for postendarterectomy stenosis: Long-term follow-up

2007 ◽  
Vol 45 (1) ◽  
pp. 118-123 ◽  
Author(s):  
Gerrit J. de Borst ◽  
Rob G.A. Ackerstaff ◽  
Jean-Paul P.M. de Vries ◽  
Erik D vd Pavoordt ◽  
Jan Albert Vos ◽  
...  
Keyword(s):  
Carotid Angioplasty ◽  
Long Term Follow Up ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Safety and Efficacy of Carotid Angioplasty and Stenting in High-Risk Patients

2006 ◽  
Vol 72 (8) ◽  
pp. 694-699 ◽  
Author(s):  
Rabih A. Chaer ◽  
Brian G. Derubertis ◽  
Susan M. Trocciola ◽  
Stephanie C. Lin ◽  
Robert Hynecek ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
High Risk ◽  
Confidence Interval ◽  
Carotid Angioplasty ◽  
Safety And Efficacy ◽  
High Risk Patients ◽  
Risk Patients ◽  
Angioplasty And Stenting ◽  
Carotid Angioplasty And Stenting

Performance of carotid endarterectomy (CEA) may be associated with an increased risk in patients with significant comorbid medical conditions, neck irradiation, or previous CEA. This study compared the results of CEA with carotid angioplasty and stenting (CAS) in high-risk patients treated for carotid stenosis. Five hundred forty-five patients who underwent CEA and 148 patients who underwent CAS were evaluated. For patients undergoing CEA, general anesthesia was used in 91 per cent, electroencephalographic monitoring was used in 63 per cent, and shunting was performed in 19.8 per cent. Cerebral protection devices were used in 145/148 of CAS cases, and self-expanding stents were used in all cases. Evaluated end points included major cardiovascular events, and a composite of death, stroke, or myocardial infarction for the duration of the follow-up. Mean follow-up was 18 months for CAS and 23 months for CEA. Significant differences were present in patient age (CAS, 75 ± 11.0 years vs CEA, 71 ± 9 years, P = 0.012), however, there were no significant differences ( P = NS) in gender or smoking history. The mean modified Goldman Score was significantly higher for CAS (21.1 ± 14.8 [95% confidence interval = 18, 24]) than for CEA (6.3 ± 6.8 [95% confidence interval = 5.7, 6.9]; P = 0.0001) patients. The incidence of periprocedural complications did not vary significantly between patients treated with CAS (CVA, 1.4%; myocardial infarction [MI], 1.4%; death, 0.7%; CVA/MI/death, 3.4%) compared with CEA (CVA, 1.8%; MI, 1.1%; death, 0.4%; CVA/MI/death, 4.0%). CAS is equivalent to CEA in safety and efficacy, even when performed in patients who may be at increased surgical risk.

Sign in / Sign up

Export Citation Format

Share Document